Treatment intensification might not improve survival in high-grade B-cell lymphoma with a concurrent MYC and BCL2 and/or BCL6 rearrangement: A retrospective, multicenter, pooled analysis

Vanja Zeremski; Ellen D. McPhail; Thomas M. Habermann; Francesca Schieppati; Niklas Gebauer; Theodoros P. Vassilakopoulos; Dimitrios Mougiakakos

doi:10.1002/hon.3130

Treatment intensification might not improve survival in high-grade B-cell lymphoma with a concurrent MYC and BCL2 and/or BCL6 rearrangement: A retrospective, multicenter, pooled analysis

Vanja Zeremski^*, Ellen D. McPhail, Thomas M. Habermann, Francesca Schieppati, Niklas Gebauer, Theodoros P. Vassilakopoulos, Dimitrios Mougiakakos

^*Korrespondierende/r Autor/-in für diese Arbeit

2 Zitate (Scopus)

Originalsprache	Englisch
Zeitschrift	Hematological Oncology
Jahrgang	41
Ausgabenummer	4
Seiten (von - bis)	776-780
Seitenumfang	5
ISSN	0278-0232
DOIs	https://doi.org/10.1002/hon.3130
Publikationsstatus	Veröffentlicht - 10.2023

Strategische Forschungsbereiche und Zentren

Profilbereich: Lübeck Integrated Oncology Network (LION)
Zentren: Universitäres Cancer Center Schleswig-Holstein (UCCSH)

DFG-Fachsystematik

2.22-14 Hämatologie, Onkologie

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

Dokumente

10.1002/hon.3130

Weitere Links

Link to publication in Scopus

Zitieren

Zeremski, V., McPhail, E. D., Habermann, T. M., Schieppati, F., Gebauer, N., Vassilakopoulos, T. P., & Mougiakakos, D. (2023). Treatment intensification might not improve survival in high-grade B-cell lymphoma with a concurrent MYC and BCL2 and/or BCL6 rearrangement: A retrospective, multicenter, pooled analysis. Hematological Oncology, 41(4), 776-780. https://doi.org/10.1002/hon.3130

@article{1d1244254f1c46beb480ffbdca963bdd,

title = "Treatment intensification might not improve survival in high-grade B-cell lymphoma with a concurrent MYC and BCL2 and/or BCL6 rearrangement: A retrospective, multicenter, pooled analysis",

author = "Vanja Zeremski and McPhail, \{Ellen D.\} and Habermann, \{Thomas M.\} and Francesca Schieppati and Niklas Gebauer and Vassilakopoulos, \{Theodoros P.\} and Dimitrios Mougiakakos",

year = "2023",

month = oct,

doi = "10.1002/hon.3130",

language = "English",

volume = "41",

pages = "776--780",

journal = "Hematological Oncology",

issn = "0278-0232",

publisher = "John Wiley and Sons Ltd",

number = "4",

}

Zeremski, V, McPhail, ED, Habermann, TM, Schieppati, F, Gebauer, N, Vassilakopoulos, TP & Mougiakakos, D 2023, 'Treatment intensification might not improve survival in high-grade B-cell lymphoma with a concurrent MYC and BCL2 and/or BCL6 rearrangement: A retrospective, multicenter, pooled analysis', Hematological Oncology, Jg. 41, Nr. 4, S. 776-780. https://doi.org/10.1002/hon.3130

Treatment intensification might not improve survival in high-grade B-cell lymphoma with a concurrent MYC and BCL2 and/or BCL6 rearrangement: A retrospective, multicenter, pooled analysis. / Zeremski, Vanja; McPhail, Ellen D.; Habermann, Thomas M. et al.
in: Hematological Oncology, Jahrgang 41, Nr. 4, 10.2023, S. 776-780.

Publikation: Beiträge in Fachzeitschriften › Briefe › Begutachtung

TY - JOUR

T1 - Treatment intensification might not improve survival in high-grade B-cell lymphoma with a concurrent MYC and BCL2 and/or BCL6 rearrangement

T2 - A retrospective, multicenter, pooled analysis

AU - Zeremski, Vanja

AU - McPhail, Ellen D.

AU - Habermann, Thomas M.

AU - Schieppati, Francesca

AU - Gebauer, Niklas

AU - Vassilakopoulos, Theodoros P.

AU - Mougiakakos, Dimitrios

PY - 2023/10

Y1 - 2023/10

UR - https://www.scopus.com/pages/publications/85150886046

U2 - 10.1002/hon.3130

DO - 10.1002/hon.3130

M3 - Letters

C2 - 36945194

AN - SCOPUS:85150886046

SN - 0278-0232

VL - 41

SP - 776

EP - 780

JO - Hematological Oncology

JF - Hematological Oncology

IS - 4

ER -